Indian pharmaceutical giant Ranbaxy announced at a conference in New Delhi that it has developed a new "indigenous" anti-malaria drug.
The new drug, called Synriam, which is effective against the deadliest malaria microbe, Plasmodium Falciparum, would be a boon for millions of malaria patients around the globe, said Ranbaxy chief executive and managing director Arun Sawhney.
No comments:
Post a Comment